| Primary |
| Contraception |
25.0% |
| Metrorrhagia |
25.0% |
| Off Label Use |
25.0% |
| Vomiting |
25.0% |
|
| Injury |
25.0% |
| Laryngitis |
25.0% |
| Liver Disorder |
25.0% |
| Vomiting |
25.0% |
|
| Secondary |
| Prostate Cancer |
17.1% |
| Product Used For Unknown Indication |
11.7% |
| Epilepsy |
9.9% |
| Hormone Replacement Therapy |
9.9% |
| Hypertension |
6.3% |
| Asthma |
5.4% |
| Prostate Cancer Stage Iv |
5.4% |
| Psychotic Disorder |
5.4% |
| Contraception |
4.5% |
| Drug Use For Unknown Indication |
4.5% |
| Restless Legs Syndrome |
3.6% |
| Transgender Hormonal Therapy |
2.7% |
| Atrial Fibrillation |
1.8% |
| Benign Prostatic Hyperplasia |
1.8% |
| Diabetes Mellitus |
1.8% |
| Embolic Stroke |
1.8% |
| Growth Hormone Deficiency |
1.8% |
| Hyperglycaemia |
1.8% |
| Hyperuricaemia |
1.8% |
| Amenorrhoea |
0.9% |
|
| Pulmonary Embolism |
27.6% |
| Feeling Hot |
10.3% |
| Death |
6.9% |
| Insomnia |
6.9% |
| Malignant Melanoma |
6.9% |
| Breast Cancer Female |
3.4% |
| Cholecystectomy |
3.4% |
| Cushingoid |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Liver Disorder |
3.4% |
| Migraine |
3.4% |
| Pregnancy On Oral Contraceptive |
3.4% |
| Respiratory Distress |
3.4% |
| Syncope |
3.4% |
| Twin Pregnancy |
3.4% |
| Weight Increased |
3.4% |
| White Blood Cell Count Increased |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.7% |
| Prostate Cancer |
11.6% |
| Prostate Cancer Stage Iv |
8.9% |
| Contraception |
7.0% |
| Hypertension |
5.5% |
| Drug Use For Unknown Indication |
4.8% |
| Cancer Pain |
2.9% |
| Rheumatoid Arthritis |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Hiv Infection |
2.2% |
| Pain |
2.2% |
| Prophylaxis |
2.2% |
| Hypothyroidism |
1.9% |
| Depressed Mood |
1.6% |
| Heart Rate Increased |
1.6% |
| Metastases To Bone |
1.6% |
| Oropharyngeal Pain |
1.6% |
| Pharyngitis |
1.6% |
| Thyroid Disorder |
1.6% |
| Crohn's Disease |
1.4% |
|
| Interstitial Lung Disease |
11.7% |
| Prostate Cancer Stage Iv |
10.0% |
| Prostate Cancer |
6.7% |
| Thyroid Neoplasm |
6.7% |
| Abdominal Mass |
5.0% |
| Abortion Spontaneous |
5.0% |
| Blindness |
5.0% |
| Drug Exposure During Pregnancy |
5.0% |
| Jaundice Cholestatic |
5.0% |
| Renal Failure Acute |
5.0% |
| Tooth Loss |
5.0% |
| Angina Pectoris |
3.3% |
| Choroid Melanoma |
3.3% |
| Drug Interaction |
3.3% |
| Dyspnoea |
3.3% |
| Epstein-barr Virus Antibody Positive |
3.3% |
| Failure To Thrive |
3.3% |
| Foot Deformity |
3.3% |
| Idiopathic Thrombocytopenic Purpura |
3.3% |
| Intestinal Resection |
3.3% |
|
| Interacting |
| Hormone Therapy |
33.3% |
| Interstitial Lung Disease |
19.0% |
| Prostate Cancer |
14.3% |
| Hypertension |
9.5% |
| Angina Pectoris |
4.8% |
| Myalgia |
4.8% |
| Pneumonia |
4.8% |
| Pollakiuria |
4.8% |
| Thyroid Disorder |
4.8% |
|
| Drug Interaction |
33.3% |
| Hepatic Function Abnormal |
33.3% |
| Liver Disorder |
33.3% |
|
